Bio-Reference Laboratories, Inc. (BRLI)
$32.80
0.86 (+2.69%)
| CAPS Rating |
|
|---|---|
| Open | $32.28 |
| Previous Close | $31.94 |
| Daily Range | $32.28 - $33.11 |
| 52-Week Range | $18.35 - $36.25 |
| Market Cap | $453.58M |
| P/E Ratio | 22.18 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 38,314 |
| Average Daily Volume | 75,000 |
How do you think BRLI will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
BRLI Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
BRLI News and Commentary
- 5-Star Stocks on the Upswing – The Motley Fool
- UPDATE 1-Bio-Reference Labs Q3 beats mkt; shrs hit lifetime high – Reuters
- 7 Shots at Superior Returns – The Motley Fool
- 5-Star Stocks on the Upswing – The Motley Fool
- 2 Stocks Hitting High Notes – The Motley Fool
- 5-Star Stocks on the Upswing – The Motley Fool
- 5-Star Stocks on the Upswing – The Motley Fool
- 5-Star Stocks on the Upswing – The Motley Fool
- 5-Star Stocks Poised to Pop: Quest Diagnostics – The Motley Fool
- 4-Star Stocks on the Upswing – The Motley Fool
- 5-Star Stocks on the Upswing – The Motley Fool
- Medicine Gets a Little More Personal – The Motley Fool
- 5-Star Stocks Poised to Pop: LabCorp – The Motley Fool
- MEDTOX Fails the Test – The Motley Fool
- Wednesday's Top 5 Growth Winners – The Motley Fool
- Bio-Reference Labs Passes the Test – The Motley Fool
- Foolish Forecast: A Test From BioReference Labs – The Motley Fool
- The Latest Procedure From Quest Diagnostics – The Motley Fool
- Big Gains for a Little Lab-Tester – The Motley Fool
- Foolish Forecast: Bio-Reference Labs Nudges Competitors – The Motley Fool


RSS Headlines
Fool UK